Your browser doesn't support javascript.
Systemic vasculitis: one year in review 2023.
Moretti, Michele; Treppo, Elena; Monti, Sara; La Rocca, Gaetano; Del Frate, Giulia; Delvino, Paolo; Italiano, Nazzareno; Di Cianni, Federica; D'Alessandro, Francesco; Talarico, Rosaria; Ferro, Francesco; Quartuccio, Luca; Baldini, Chiara.
  • Moretti M; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Treppo E; Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Monti S; Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  • La Rocca G; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Del Frate G; Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Delvino P; Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  • Italiano N; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Di Cianni F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • D'Alessandro F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Talarico R; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Ferro F; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Quartuccio L; Clinic of Rheumatology, Department of Medical and Biological Sciences, University Hospital Santa Maria della Misericordia, Udine, Italy.
  • Baldini C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. chiara.baldini74@gmail.com.
Clin Exp Rheumatol ; 41(4): 765-773, 2023 04.
Article in English | MEDLINE | ID: covidwho-2300379
ABSTRACT
Systemic vasculitides are heterogeneous disabling diseases characterised by chronic inflammation of the blood vessels potentially leading to tissue destruction and organ failure. The recent COVID-19 pandemic has had a significant impact on the epidemiology and management of patients with systemic vasculitis. In parallel, new insights have been provided on systemic vasculitis pathogenetic mechanisms, possible new therapeutic targets, and newer glucocorticoid-sparing treatments with better safety profiles. As in the previous annual reviews of this series, in this review we will provide a critical digest of the most recent literature regarding pathophysiology, clinical manifestations, diagnostic tools and treatment options in small- and large-vessel vasculitis focusing on precision medicine in vasculitis.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vasculitis / Systemic Vasculitis / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2023 Document Type: Article Affiliation country: Clinexprheumatol

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vasculitis / Systemic Vasculitis / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal: Clin Exp Rheumatol Year: 2023 Document Type: Article Affiliation country: Clinexprheumatol